Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Kate Johnson

    News

    Black Women With Breast Cancer Face Clinical Inequities

    Author:
    Kate Johnson
    Publish date: July 26, 2024

    Retrospective analysis finds no clinical trial enrollment, reduced use of targeted treatment, and shortened survival.

    • Read More

    News

    Cognitive Decline Minimal After Endocrine + CDK4/6 Inhibition in BC

    Author:
    Kate Johnson
    Publish date: July 17, 2024

    Authors investigate cognitive functioning in the same cohort used in the SONIA trial and a matched control group of individuals that did not have...

    • Read More

    News

    Eribulin Similar to Taxane When Paired With Dual HER2 Blockade in BC

    Author:
    Kate Johnson
    Publish date: July 10, 2024

    Patients with HER2-positive, locally advanced or metastatic breast cancer who cannot tolerate the standard taxane-based regimen have a new option...

    • Read More

    News

    PFS Benefits Seen With Palbociclib + Endocrine Therapy in Breast Cancer

    Author:
    Kate Johnson
    Publish date: July 10, 2024

    Palbociclib plus endocrine therapy or chemotherapy: Which is best in HR+/HER2- metastatic breast cancer?

    • Read More

    News

    Adjuvant Avelumab Benefits Seen in High Risk, Triple Negative BC

    Author:
    Kate Johnson
    Publish date: July 8, 2024

    Researchers conduct first randomized phase 3 trial of patients with TNBC treated with adjuvant avelumab.

    • Read More

    News

    Neurofilament Light Chain Detects Early Chemotherapy-Related Neurotoxicity

    Author:
    Kate Johnson
    Publish date: June 26, 2024

    “Nfl after a single cycle could detect axonal degeneration,” says the lead author of new research.

    • Read More

    News

    Inavolisib Added to Standard Tx Shows Sustained Benefit in Advanced BC

    Author:
    Kate Johnson
    Publish date: June 19, 2024

    An expanded analysis of the INAVO120 trial looks at time from randomization to end of next-line treatment, time to first chemotherapy, and patient...

    • Read More

    News

    ‘Groundbreaking’ Trial Shows Survival Benefits in Lung Cancer

    Author:
    Kate Johnson
    Publish date: June 5, 2024

    Presentation on treatment for limited stage small cell lung cancer draws rounds of applause at the annual meeting of the American Society of...

    • Read More

    News

    Neoadjuvant Checkpoint Inhibition Study Sets New Standard of Care in Melanoma

    Author:
    Kate Johnson
    Publish date: June 4, 2024

    Results of the first phase 3 oncology study to test checkpoint inhibition without chemotherapy were presented at the annual meeting of the...

    • Read More

    News

    CARACO: Study Shows Safety of Leaving Uninvolved Lymph Nodes in Ovarian Cancer

    Author:
    Kate Johnson
    Publish date: June 3, 2024

    Retroperitoneal pelvic and para-aortic lymphadenectomy only adds toxicity without benefit, says an author of research presented at the annual...

    • Read More

    News

    Postinfectious Cough: Are Treatments Ever Warranted?

    Author:
    Kate Johnson
    Publish date: February 15, 2024

    Physicians weigh in on when and how to treat a lingering cough.

    • Read More

    News

    Stiff person syndrome: When a rare disorder hits the headlines

    Author:
    Kate Johnson
    Publish date: October 13, 2023

    Awareness of this disorder is increasing, but clinicians are challenged to apply the proper workupto avoid wrong turns in identifying affected...

    • Read More

    News

    COVID nonvaccination linked with avoidable hospitalizations

    Author:
    Kate Johnson
    Publish date: June 5, 2023

    Eligible unvaccinated patients with COVID-19 had a nearly 10-fold higher risk for hospitalization than did patients who were fully vaccinated with...

    • Read More

    News

    Which drug best reduces sleepiness in patients with OSA?

    Author:
    Kate Johnson
    Publish date: May 22, 2023

    “Although solriamfetol appears most effective, comorbid hypertension and costs may be barriers to its use.”

    • Read More

    News

    Repeated CTs in childhood linked with increased cancer risk

    Author:
    Kate Johnson
    Publish date: April 27, 2023

    Children exposed to four or more CT scans at or before age 6 years had the highest risk for cancer.

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery